Daniel Sánchez-Cano

Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group

R. Ríos-Fernandez, N. Ortego-Centeno, J. Callejas, 2018, Rheumatology International.

Effect of rituximab on refractory Wegener granulomatosis with predominant granulomatous disease.

J. Callejas-Rubio, N. Ortego-Centeno, J. Callejas-Rubio, 2008, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.